Cytec Down on Low Volume – Zacks Tale of the Tape
Zacks Market Commentaries (May 5th, 2009) Writes:
Cytec saw declining sales across all its chemical product lines in its latest first quarter due to the slump in the auto, construction and general industrial markets. As a result, revenue stood at $612 million, down from $973 million in the year-ago quarter.
In April, the company posted first-quarter earnings of 6 cents per share, which missed the consensus by 25 cents.
The full-year estimate is down to $1.36 per share from the previous month's $2.24 as all of the 6 covering analysts reduced expectations.
Cytec is a Zacks #5 Rank ("Strong Sell") company.
"CYT" Free Stock Analysis: Buy? Sell? Hold?Zacks Investment Researchcent;, chemical product lines, Cytec Industries Inc.;, Market Commentary, Stocks to Watch, USD, Zacks Market Commentaries


![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)


